The A-share brain engineering concept saw a short-term surge, with Innovative Medical hitting the daily limit, and Thalys, Rongtai Health, ZJDR, CASIT, Sanbo Neuroscience, and Haojiang Intelligent following suit

CASIT: The intelligent paving robot is currently in the testing phase

On August 7th, CASIT stated during an institutional research that the intelligent loading robot is currently being trialed on-site, with the second phase focusing on functional optimization and enhancement; the intelligent paving robot is in the testing phase. In the future, the company will strive towards industrialization and promotion

CASIT executive Zhong Yong plans to reduce holdings of no more than 180,000 shares

According to the announcement released by CASIT, Mr. Zhong Yong, a senior management personnel holding 0.25% of the company's shares, plans to reduce his holdings of the company's shares by no more than 180,000 shares (i.e., no more than 0.06% of the company's total share capital) through centralized bidding within 3 months after 15 trading days from the date of this announcement

Brain-computer interface concept stocks experienced afternoon fluctuations, with APON rising over 10%. BeiYikang, CTN, CASIT, Innovative Medical, OIMEC, and Sanbo also saw gains

CASIT: Intelligent loading robots have been trialed internally at the Road and Bridge Group

On May 29th, CASIT stated during an on-site visit by institutions that the company's intelligent loading robots utilize multimodal technologies such as machine vision and intelligent analysis, radar, and autonomous driving. The sensing and identification accuracy reaches 5CM, far exceeding domestic standards. Powered by electricity, multiple robots can automatically collaborate without human control and can work continuously for 24 hours in the absence of lighting, ensuring green safety and significantly reducing costs. Currently, the intelligent loading robots are being trialed internally at the Road and Bridge Group and have initiated comprehensive market promotion